Autism pre-birth gene test. Here?
Jul 22 2008
Has the day finally come?
CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has launched an updated version of its ATScan™ test for pre-disposition screening for autism, through its wholly owned subsidiary CombiMatrix Molecular Diagnostics (CMDX). The ATScan test has been updated to encompass recent discoveries published in the journal, Science, which confirm the role of several new genomic imbalances in the etiology of Autism Spectrum Disorder (ASD)
The product page for this testing is here.
CMDX is proud to offer the first of our ATScan™ suite of BAC (Bacterial Artificial Chromosome) array CGH (Comparative Genomic Hybridization) based tests. ATScan™ is designed to detect known genomic copy-number variations (CNVs) associated with Autism Spectrum Disorder (ASD) and this test is now available to our physicians and consumers.
I can’t find anything out about this test – such as price or reliability. Any comments would be welcomed.
› 10 Comments



















